Weighted Average Number of Shares Outstanding, Diluted of DEXCOM INC from 30 Jun 2013 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
DEXCOM INC quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 30 Jun 2013 to 31 Dec 2025.
  • DEXCOM INC Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 31 Dec 2025 was 405,500,000, a 1.7% decline year-over-year.
  • DEXCOM INC annual Weighted Average Number of Shares Outstanding, Diluted for 2025 was 405,500,000, a 1.7% decline from 2024.
  • DEXCOM INC annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 412,700,000, a 3% decline from 2023.
  • DEXCOM INC annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 425,500,000, a 0.47% decline from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

DEXCOM INC Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 405,500,000 -7,200,000 -1.7% 01 Oct 2025 31 Dec 2025 10-K 12 Feb 2026 2025 FY
Q3 2025 407,400,000 -2,800,000 -0.68% 01 Jul 2025 30 Sep 2025 10-Q 30 Oct 2025 2025 Q3
Q2 2025 408,200,000 -8,600,000 -2.1% 01 Apr 2025 30 Jun 2025 10-Q 30 Jul 2025 2025 Q2
Q1 2025 407,500,000 -9,200,000 -2.2% 01 Jan 2025 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 412,700,000 -12,800,000 -3% 01 Oct 2024 31 Dec 2024 10-K 12 Feb 2026 2025 FY
Q3 2024 410,200,000 -16,600,000 -3.9% 01 Jul 2024 30 Sep 2024 10-Q 30 Oct 2025 2025 Q3
Q2 2024 416,800,000 -14,700,000 -3.4% 01 Apr 2024 30 Jun 2024 10-Q 30 Jul 2025 2025 Q2
Q1 2024 416,700,000 -1,800,000 -0.43% 01 Jan 2024 31 Mar 2024 10-Q 01 May 2025 2025 Q1
Q4 2023 425,500,000 -2,000,000 -0.47% 01 Oct 2023 31 Dec 2023 10-K 12 Feb 2026 2025 FY
Q3 2023 426,800,000 +1,000,000 +0.24% 01 Jul 2023 30 Sep 2023 10-Q 24 Oct 2024 2024 Q3
Q2 2023 431,500,000 +10,100,000 +2.4% 01 Apr 2023 30 Jun 2023 10-Q 25 Jul 2024 2024 Q2
Q1 2023 418,500,000 -10,200,000 -2.4% 01 Jan 2023 31 Mar 2023 10-Q 25 Apr 2024 2024 Q1
Q4 2022 427,500,000 -1,300,000 -0.3% 01 Oct 2022 31 Dec 2022 10-K 18 Feb 2025 2024 FY
Q3 2022 425,800,000 -4,500,000 -1% 01 Jul 2022 30 Sep 2022 10-Q 26 Oct 2023 2023 Q3
Q2 2022 421,400,000 -5,700,000 -1.3% 01 Apr 2022 30 Jun 2022 10-Q 27 Jul 2023 2023 Q2
Q1 2022 428,700,000 +324,100,000 +310% 01 Jan 2022 31 Mar 2022 10-Q 27 Apr 2023 2023 Q1
Q4 2021 428,800,000 +8,400,000 +2% 01 Oct 2021 31 Dec 2021 10-K 08 Feb 2024 2023 FY
Q3 2021 430,300,000 +330,800,000 +332% 01 Jul 2021 30 Sep 2021 10-Q 27 Oct 2022 2022 Q3
Q2 2021 427,100,000 +330,100,000 +340% 01 Apr 2021 30 Jun 2021 10-Q 28 Jul 2022 2022 Q2
Q1 2021 104,600,000 +10,500,000 +11% 01 Jan 2021 31 Mar 2021 10-Q 28 Apr 2022 2022 Q1
Q4 2020 420,400,000 +328,100,000 +355% 01 Oct 2020 31 Dec 2020 10-K 09 Feb 2023 2022 FY
Q3 2020 99,500,000 +7,000,000 +7.6% 01 Jul 2020 30 Sep 2020 10-Q 28 Oct 2021 2021 Q3
Q2 2020 97,000,000 +5,900,000 +6.5% 01 Apr 2020 30 Jun 2020 10-Q 29 Jul 2021 2021 Q2
Q1 2020 94,100,000 +3,800,000 +4.2% 01 Jan 2020 31 Mar 2020 10-Q 29 Apr 2021 2021 Q1
Q4 2019 92,300,000 01 Oct 2019 31 Dec 2019 10-K 14 Feb 2022 2021 FY
Q3 2019 92,500,000 +2,200,000 +2.4% 01 Jul 2019 30 Sep 2019 10-Q 27 Oct 2020 2020 Q3
Q2 2019 91,100,000 +1,700,000 +1.9% 01 Apr 2019 30 Jun 2019 10-Q 28 Jul 2020 2020 Q2
Q1 2019 90,300,000 01 Jan 2019 31 Mar 2019 10-Q 28 Apr 2020 2020 Q1
Q3 2018 90,300,000 +3,600,000 +4.2% 01 Jul 2018 30 Sep 2018 10-Q 06 Nov 2019 2019 Q3
Q2 2018 89,400,000 +2,000,000 +2.3% 01 Apr 2018 30 Jun 2018 10-Q 31 Jul 2019 2019 Q2
Q3 2017 86,700,000 01 Jul 2017 30 Sep 2017 10-Q 06 Nov 2018 2018 Q3
Q2 2017 87,400,000 +3,800,000 +4.5% 01 Apr 2017 30 Jun 2017 10-Q 01 Aug 2018 2018 Q2
Q2 2016 83,600,000 +4,000,000 +5% 01 Apr 2016 30 Jun 2016 10-Q 01 Aug 2017 2017 Q2
Q3 2015 80,500,000 +4,400,000 +5.8% 01 Jul 2015 30 Sep 2015 10-Q 04 Nov 2015 2015 Q3
Q2 2015 79,600,000 +4,300,000 +5.7% 01 Apr 2015 30 Jun 2015 10-Q 05 Aug 2015 2015 Q2
Q3 2014 76,100,000 +4,700,000 +6.6% 01 Jul 2014 30 Sep 2014 10-Q 04 Nov 2015 2015 Q3
Q2 2014 75,300,000 +4,400,000 +6.2% 01 Apr 2014 30 Jun 2014 10-Q 05 Aug 2015 2015 Q2
Q3 2013 71,400,000 01 Jul 2013 30 Sep 2013 10-Q 06 Nov 2014 2014 Q3
Q2 2013 70,900,000 01 Apr 2013 30 Jun 2013 10-Q 06 Aug 2014 2014 Q2

DEXCOM INC Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 405,500,000 -7,200,000 -1.7% 01 Jan 2025 31 Dec 2025 10-K 12 Feb 2026 2025 FY
2024 412,700,000 -12,800,000 -3% 01 Jan 2024 31 Dec 2024 10-K 12 Feb 2026 2025 FY
2023 425,500,000 -2,000,000 -0.47% 01 Jan 2023 31 Dec 2023 10-K 12 Feb 2026 2025 FY
2022 427,500,000 -1,300,000 -0.3% 01 Jan 2022 31 Dec 2022 10-K 18 Feb 2025 2024 FY
2021 428,800,000 +8,400,000 +2% 01 Jan 2021 31 Dec 2021 10-K 08 Feb 2024 2023 FY
2020 420,400,000 +328,100,000 +355% 01 Jan 2020 31 Dec 2020 10-K 09 Feb 2023 2022 FY
2019 92,300,000 +4,100,000 +4.6% 01 Jan 2019 31 Dec 2019 10-K 14 Feb 2022 2021 FY
2018 88,200,000 +1,900,000 +2.2% 01 Jan 2018 31 Dec 2018 10-K 11 Feb 2021 2020 FY
2017 86,300,000 01 Jan 2017 31 Dec 2017 10-K 13 Feb 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.